Biolinq raises $100M for intradermal glucose sensor for type 2 diabetes

The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.

Apr 22, 2025 - 16:28
 0
Biolinq raises $100M for intradermal glucose sensor for type 2 diabetes
The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.